Received Feb 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 2 | EW0183 | OT |
seizures / epilepsy; seizures / epilepsy; This is a spontaneous report received from a Consumer or other non HCP. A 27-year-old female patient received BNT162b2 (BNT162B2), on 18May2021 as dose 2, single (Lot number: EW0183) at the age of 27 years intramuscular for covid-19 immunisation. The patient's relevant medical history included: "Anxiety" (unspecified if ongoing). Concomitant medication(s) included: LAMOTRIGINE taken for anxiety. Vaccination history included: BNT162b2 (Dose 1, Single, Intramuscular, Batch number: EV0175, in the AM), administration date: 27Apr2021, when the patient was 27-year-old, for Covid-19 Immunization, reaction(s): "Seizures", "Epilepsy". The following information was reported: SEIZURE (disability) with onset 19May2021, outcome "not recovered", EPILEPSY (disability), outcome "unknown" and all described as "seizures / epilepsy". The event "seizures / epilepsy" required physician office visit. Therapeutic measures were taken as a result of epilepsy, seizure which included Keppra 3000 mg, Lamictal 200mg, Vimpat 400mg, Onfi 40 mg.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202400161429 Same patient, product and event different dose;
Medical History/Concurrent Conditions: Anxiety
LAMOTRIGINE